Article

Persistent Levels of Anti-SARS-CoV-2 IgM Antibody Measured by an In-house ELISA in a Convalescent Latin Population Positively Correlate with the Neutralizing Percentages to Several Variants of Concern

2024-08-19

Abstract excerpt

The coronavirus SARS-CoV-2 is the causative agent for the COVID-19 first registered in Wuhan, China and responsible for more than 6 million deaths worldwide. Currently, RT-PCR is the gold standard method for diagnosing COVID-19. However, serological tests are needed for screening acute disease diagnosis and screening large populations during the COVID-19 outbreak. Herein we described the development of an in-house...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 15ecb81f-a4ad-5638-a189-38e4db2a3fd4
DOI: 10.20944/preprints202408.1226.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Persistent Levels of Anti-SARS-CoV-2 IgM Antibody Measured by an In-house ELISA in a Convalescent Latin Population Positively Correlate with the Neutralizing Percentages to Several Variants of ConcernDOI 10.20944/preprints202408.1226.v1Read

Emergency Response for Evaluating SARS-CoV-2 Immune Status, Seroprevalence and Convalescent Plasma in ArgentinaSemantic proximity Read

Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunitySemantic proximity Read

Diagnostic accuracy of six commercial SARS-CoV-2 IgG/total antibody assays and identification of SARS-CoV-2 neutralizing antibodies in convalescent seraSemantic proximity Read

Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2Semantic proximity Read

Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan – Implications for the Longevity of Antibodies Against SARS-CoV-2Semantic proximity Read

Exploratory study of antibody titers against SARS-CoV-2 using an indirect immunoperoxidase assay in COVID-19 patients and vaccinated volunteersSemantic proximity Read

SARS-CoV-2 antibody responses determine disease severity in COVID-19 infected individualsSemantic proximity Read

COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in salivaSemantic proximity Read

The Dynamic Changes of Antibodies against SARS-CoV-2 during the Infection and Recovery of COVID-19Semantic proximity Read

Development of in-house, indirect ELISAs for the detection of SARS-CoV-2 spike protein-associated serology in COVID-19 patients in PanamaSemantic proximity Read

Analysis of IgG, IgA, and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccinesSemantic proximity Read

Correlation of the commercial anti-SARS-CoV-2 receptor binding domain antibody test with the chemiluminescent reduction neutralizing test and possible detection of antibodies to emerging variantsSemantic proximity Read